Rare diseases
Investigational molecules
Locations
706 conditions with trials, the busiest first
3 924 trials across Europe, recruiting first
Study of vinorelbine and cisplatin with radiation therapy for patients with castration- and taxane-resistant prostate cancer
EstoniaStudy of durvalumab and tremelimumab with or without hepatic arterial infusion of gemcitabine and oxaliplatin in patients with high tumor burden hepatocellular carcinoma
FranceSafety and efficacy study of nadofaragene firadenovec administered to the renal pelvis in adults with low-grade upper tract urothelial carcinoma
FranceStudy of dornase alfa and cisplatin treatment for patients with refractory germ cell cancer
SlovakiaStudy of Ferumoxtran-10 Enhanced MRI for Detecting Lymph Node Metastases in Patients with Esophageal Cancer
The NetherlandsStudy of PSMA PET imaging versus standard imaging to guide radiation therapy in patients with intermediate or high-risk prostate cancer
GermanyStudy of disitamab vedotin alone or with pembrolizumab in patients with locally advanced or metastatic urothelial cancer that expresses HER2
BelgiumStudy of Cannabidiol and Nutritional Supplements to Improve Muscle Health in Adults with Head and Neck Cancer Before Surgery
FranceStudy of tucatinib and trastuzumab for patients with HER3-mutant and HER2-not amplified metastatic breast cancer
FranceStudy of dronabinol and cannabidiol oral solution for symptom relief in advanced cancer patients receiving opioid treatment
ItalyStudy of brentuximab vedotin for maintenance therapy in patients with cutaneous T-cell lymphoma after stem cell transplant
FranceEvaluating shorter duration of pembrolizumab and pemetrexed treatment in patients with metastatic non-small cell lung cancer who have not progressed after 6 months
The NetherlandsThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
